Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Development
Elderly cancer patients significantly underrepresented in cancer trials
December 12th, 2004
A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study was published in the Journal of Clinical Oncology. "If elderly patients do not participate in clinical trials, the treatments resulting from those trials may not be appropriate for them," said Lilia Talarico, MD, of the Division of Oncology Drug Products and Center for Drug Evaluation and Research at the U.S. Food and Drug Administration and lead author of the study. "This is a significant concern, given that elderly patients represent the majority of cancer patients in the U.S."...
Source: Medical Letter on the CDC & FDA (2004-12-12)
|
